Cancer Molecular Imaging Program monthly Series featuring Dr. Weibo Cai
PARP inhibition potentiates low dose temozolomide in cancer cell lines
- Date: February 27, 2017 4:00 PM - 5:00 PM
- Location: 13-105 CHS
Los Angeles, California 90095
Weibo Cai, Ph.D.
Radiology Medical Physics Biomedical Engineering
University of Wisconsin, Madison
Dr. Erika von Euw’s primary focus is on translational cancer research. She is developing a program that advances the discovery of novel therapeutic projects by combining the scientific strengths of the investigators in the Translational Oncology Research Laboratory with the business knowledge of former industry professionals now at UCLA to discover new therapeutic targets for cancer treatment. Her goal is to develop ADC (Antibody Drug Conjugates), rnAb (monoclonal Antibody) or small molecules with the potential to bring better targeted therapies to cancer patients and improve patient survival.
Light lunch served
Sponsored by UCLA's Jonsson Comprehensive Cancer Center Cancer Molecular Imaging program